These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9677163)

  • 21. Characterization of JC virus in cerebrospinal fluid from HIV-1 infected patients with progressive multifocal leukoencephalopathy: insights into viral pathogenesis and disease prognosis.
    Marzocchetti A; Sanguinetti M; Giambenedetto SD; Cingolani A; Fadda G; Cauda R; De Luca A
    J Neurovirol; 2007 Aug; 13(4):338-46. PubMed ID: 17849317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response.
    Giudici B; Vaz B; Bossolasco S; Casari S; Brambilla AM; Lüke W; Lazzarin A; Weber T; Cinque P
    Clin Infect Dis; 2000 Jan; 30(1):95-9. PubMed ID: 10619739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.
    Hall CD; Dafni U; Simpson D; Clifford D; Wetherill PE; Cohen B; McArthur J; Hollander H; Yainnoutsos C; Major E; Millar L; Timpone J
    N Engl J Med; 1998 May; 338(19):1345-51. PubMed ID: 9571254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection: the clinical, neuroimaging, virological and evolutive characteristics in 35 patients].
    Asensi V; Cartón JA; Maradona JA; Oña M; Melón S; Martín-Roces ER; Asensi JM; Arribas JM
    Med Clin (Barc); 1999 Sep; 113(6):210-4. PubMed ID: 10472609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visual loss secondary to acquired immunodeficiency virus-related progressive multifocal leukoencephalopathy demonstrating clinical improvement with highly active antiretroviral therapy.
    Diller R; Thompson K
    Optometry; 2007 Feb; 78(2):63-70. PubMed ID: 17258160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: extended follow-up of an observational study.
    De Luca A; Giancola ML; Ammassari A; Grisetti S; Cingolani A; Larussa D; Alba L; Murri R; Ippolito G; Cauda R; Monforte A; Antinori A
    J Neurovirol; 2001 Aug; 7(4):364-8. PubMed ID: 11517418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy.
    Clifford DB; Yiannoutsos C; Glicksman M; Simpson DM; Singer EJ; Piliero PJ; Marra CM; Francis GS; McArthur JC; Tyler KL; Tselis AC; Hyslop NE
    Neurology; 1999 Feb; 52(3):623-5. PubMed ID: 10025799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Progressive multifocal leukoencephalopathy--epidemiology, clinical pictures, diagnosis and therapy].
    Kishida S
    No To Shinkei; 2007 Feb; 59(2):125-37. PubMed ID: 17315754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of viral sequences in cerebrospinal fluid of AIDS patients with cerebral white-matter lesions using polymerase chain reaction.
    Monno L; Di Stefano M; Zimatore GB; Andreula CF; Appice A; Perulli LM; Fiore JR; Pastore G; Angarano G
    AIDS; 1998 Apr; 12(6):581-90. PubMed ID: 9583597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy.
    Sainz-de-la-Maza S; Casado JL; Pérez-Elías MJ; Moreno A; Quereda C; Moreno S; Corral I
    Eur J Neurol; 2016 May; 23(5):919-25. PubMed ID: 26914970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival and prognostic factors of progressive multifocal leukoencephalopathy in people living with HIV in modern ART era.
    Jiang R; Song Z; Liu L; Mei X; Sun J; Qi T; Wang Z; Song W; Tang Y; Yang J; Xu S; Zhao B; Shen Y; Zhang R; Chen J
    Front Cell Infect Microbiol; 2023; 13():1208155. PubMed ID: 38029233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effective use of JC virus PCR for diagnosis of progressive multifocal leukoencephalopathy.
    Wang Y; Kirby JE; Qian Q
    J Med Microbiol; 2009 Feb; 58(Pt 2):253-255. PubMed ID: 19141745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study.
    Engsig FN; Hansen AB; Omland LH; Kronborg G; Gerstoft J; Laursen AL; Pedersen C; Mogensen CB; Nielsen L; Obel N
    J Infect Dis; 2009 Jan; 199(1):77-83. PubMed ID: 19007313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era.
    Antinori A; Ammassari A; Giancola ML; Cingolani A; Grisetti S; Murri R; Alba L; Ciancio B; Soldani F; Larussa D; Ippolito G; De Luca A
    J Neurovirol; 2001 Aug; 7(4):323-8. PubMed ID: 11517411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA).
    Antinori A; Cingolani A; Lorenzini P; Giancola ML; Uccella I; Bossolasco S; Grisetti S; Moretti F; Vigo B; Bongiovanni M; Del Grosso B; Arcidiacono MI; Fibbia GC; Mena M; Finazzi MG; Guaraldi G; Ammassari A; d'Arminio Monforte A; Cinque P; De Luca A;
    J Neurovirol; 2003; 9 Suppl 1():47-53. PubMed ID: 12709872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progressive multifocal leukoencephalopathy in HIV-infected patients in the era of HAART: radiological features at diagnosis and follow-up and correlation with clinical variables.
    Giancola ML; Rizzi EB; Lorenzini P; Rovighi L; Baldini F; Schininà V; Larussa D; Bibbolino C; Antinori A
    AIDS Res Hum Retroviruses; 2008 Feb; 24(2):155-62. PubMed ID: 18240958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity?
    Di Giambenedetto S; Vago G; Pompucci A; Scoppettuolo G; Cingolani A; Marzocchetti A; Tumbarello M; Cauda R; De Luca A
    Neurology; 2004 Dec; 63(12):2452-3. PubMed ID: 15623736
    [No Abstract]   [Full Text] [Related]  

  • 38. The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS.
    Geschwind MD; Skolasky RI; Royal WS; McArthur JC
    J Neurovirol; 2001 Aug; 7(4):353-7. PubMed ID: 11517416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy.
    Marzocchetti A; Di Giambenedetto S; Cingolani A; Ammassari A; Cauda R; De Luca A
    J Clin Microbiol; 2005 Aug; 43(8):4175-7. PubMed ID: 16081969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of JC virus genotype distribution and transcriptional control region rearrangements in human immunodeficiency virus-positive progressive multifocal leukoencephalopathy patients with and without highly active antiretroviral treatment.
    Ferrante P; Delbue S; Pagani E; Mancuso R; Marzocchetti A; Borghi E; Maserati R; Bestetti A; Cinque P
    J Neurovirol; 2003; 9 Suppl 1():42-6. PubMed ID: 12709871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.